Genes & biomarkers

HER2 / ERBB2 results

ERBB2 · HER2 · IHC / ISH / mutation

Protein expression, gene amplification and gene variants are different findings.

Sources checked · Introductory guide

On this page

What does this result mean?

HER2 is the protein encoded by ERBB2. IHC assesses protein expression; ISH assesses gene amplification. These differ from ERBB2 variants identified by sequencing.[1]

How does it connect to treatment?

Criteria for trastuzumab or trastuzumab deruxtecan depend on the cancer and test finding. HER2-low breast cancer and HER2-mutant lung cancer do not share a single positivity rule.[2]

What should I check in my report?

Check the IHC score, ISH result and ERBB2 variant separately. If told “HER2 negative,” ask whether the report meets a low-expression category relevant to a particular treatment.

Questions for your care team

  • Does my HER2 result describe expression, amplification or a variant?
  • Which treatments or trials fit my cancer type, stage and previous treatment?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. MedlinePlus · HER2 Tumor Marker Test (opens in a new tab)
  2. NCI · Fam-Trastuzumab Deruxtecan-nxki (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

HER2 / ERBB2 results | Cancer Encyclopedia | My Chemo Diary